View in Other Languages

MMJ PhytoTech Ltd

ASX:MMJ ISIN:AU000000MMJ4

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited (ASX:MMJ) is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.

The Company controls operations across the entire medicinal cannabis value chain through its ~59% interest in TSX-V listed Harvest One Cannabis Inc (CVE:HVST) and its 100% interest in Israeli research and development subsidiary, PhytoTech Therapeutics Ltd, both of which are strategically located in favourable jurisdictions with supportive regulatory frameworks in place.

       

News

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One Operational Update

🕔10/16/2017 1:56:41 PM 1724

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an update on its wholly-owned subsidiary United Greeneries Ltd..

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Strategy Expansion

🕔10/10/2017 1:41:17 PM 2023

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the following update on the Company's strategic direction and proposed name change to "MMJ Capital Limited".

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Appointment of Chief Financial Officer

🕔6/14/2017 9:39:26 AM 2442

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to announce the appointment of Lisa Dea as Chief Financial Officer of the Company effective immediately. Ms. Dea has also been appointed CFO of Harvest One Cannabis Inc. (CVE:HVST), and replaces Mr Kwong Choo, who will be assuming a new role as Vice President Finance of Harvest One.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Investor Update Presentation

🕔5/31/2017 8:27:32 AM 1757

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the following investor update presentation, the purpose of which is to provide shareholders with an update on the Company's activities and strategic outlook following the completion of the Harvest One Transaction last month.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Receives Approval to Conduct Phase 2 Clinical Trial for Treatment of Multiple Sclerosis Symptoms

🕔5/15/2017 8:27:22 AM 3237

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited, has received Helsinki and Ministry of Health approvals for the conducting of its Phase 2 clinical study into the safety and efficacy of its PTL201 capsules in treating spasticity related symptoms of multiple sclerosis patients.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Completion of First Shipment of Medicinal Cannabis Products into Australia

🕔5/9/2017 8:56:16 AM 2348

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, Melbourne-based HL Pharma Pty Ltd., has successfully imported its first shipment of medicinal products from the Company's Swiss-subsidiary, Satipharm AG.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One Signs Funding Agreements with PanCann

🕔5/2/2017 9:55:07 AM 4329

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Harvest One Cannabis Inc. (CVE:HVST) through its wholly-owned subsidiaries United Greeneries Ltd. and United Greeneries Saskatechwan Ltd., has entered into two separate agreements with PanCann Streaming Corp. to finance the construction of both the Lucky Lake facility and a new additional production facility to be identified.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update and Appendix 4C

🕔5/1/2017 12:09:49 PM 3814

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 March 2017.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ): Harvest One (CVE:WON.H) Announces Closure of United Greeneries and Satipharm Acquisition

🕔4/28/2017 9:18:08 AM 3535

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Harvest One Capital Inc. (CVE:WON.H) has announced the closure of the acquisition of MMJ's wholly-owned subsidiaries United Greeneries Holdings Ltd and Satipharm AG.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Completes Sale of Satipharm and United Greeneries; Acquires Interest in Harvest One Cannabis Inc. (CVE:WON.H)

🕔4/28/2017 9:10:26 AM 1681

MMJ PhytoTech Limited (ASX:MMJ) today confirms that it has closed its previously announced sale of 100% of the issued and outstanding shares of United Greeneries Holdings Ltd. and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly owned subsidiary of MMJ.

Read Full Article
###

44,925 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 198) (Last 30 Days: 1537) (Since Published: 33558) 

Markets ASX:MMJ

Company Data

    Headquarters
  • Suite 5 CPC, 145 Stirling Highway
    Nedlands WA 6009
    Australia
  • Telephone
  • +61-8-9389-3150 
  • Fax
  • +61-8-9389-3199 
  • Principal Sector
  • Ag Biotechnology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.mmjphytotech.com.au
  • E:
  • info@mmjphytotech.com.au

Company Reports

Presentations

Research Report

Quarterly Report

Social Media